US FDA OKs clinical trial on stem cell

CJ Cheil Jedang says the U.S. Food and Drug Administration has allowed its U.S. partner Neuralstem Inc. to start an early-stage human trial of its spinal cord stem cells in Lou Gehrig's disease, a fatal neuromuscular condition.

The trial, which will test the safety of the cells and the surgery procedure, will ultimately consist of 18 patients suffering from the disease, also known as amyotro...